Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(20/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(20/week)
News
United States
(579/week)
Manufacturing
(424/week)
Energy
(320/week)
Technology
(448/week)
Other Manufacturing
(341/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Camurus AB
Dec 18, 2020
Swissmedic approves Buvidal for the treatment of opioid dependence
Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Apr 02, 2020
Camurus Announces Strong First Quarter Demand for Buvidal®
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 07, 2019
Camurus Announces That FDA Grants Braeburn's Citizen Petition, Eliminating the Risk of Further Blocking of Brixadi(TM) From the US market
Jul 23, 2019
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi(TM)
Jun 20, 2019
Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly
Jun 04, 2019
Camurus Announces Publication of Phase 3 Study Results Showing Long-term Safety, Efficacy and High Rates of Patient Satisfaction With Buvidal®
May 09, 2019
Camurus Interim Report January-March 2019
Apr 09, 2019
Braeburn Initiates Court Proceedings to Overturn Exclusivity and Seeks Immediate Market Approval of Brixadi(TM) in the US
Nov 28, 2018
Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence
Nov 22, 2018
Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence
Oct 10, 2018
Camurus to Present at Jefferies 2018 London Healthcare Conference
Sep 21, 2018
CHMP Recommends Approval of Buvidal® (CAM2038) for the Treatment of Opioid Dependence
Sep 18, 2018
Camurus Announces Positive Topline Phase 3 Results for CAM2038 in Opioid Experienced Patients With Chronic Low-back Pain
Jul 16, 2018
Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
Sep 29, 2017
Camurus Announces European Medicines Agency Validation of CAM2038 Marketing Authorization Application for Treatment of Opioid Dependence
Sep 18, 2017
Camurus Announces That FDA Grants Priority Review of NDA for Weekly and Monthly CAM2038 Buprenorphine Depots for Treatment of Opioid Use Disorder
Jun 27, 2017
Rhythm and Camurus Announce Positive Initial Data for Extended-Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity
Jun 15, 2017
Braeburn Pharmaceuticals and Camurus Announce Presentations of Pivotal Clinical Study Data of Long-acting Buprenorphine
Latest News
Apr 28, 2024
HII’s Ingalls Shipbuilding Hosts Inaugural Scout Merit Badge Day
Apr 27, 2024
Summit Energy Sponsors and Participates in the Interfaith Social Services Stop the Stigma 5K
Apr 27, 2024
Owens Corning and Masonite Extend Early Participation Deadline and Announce Successful Results of Early...
Apr 27, 2024
Faraday Future Announces Nasdaq Delisting Determination and Intention to Appeal
Apr 27, 2024
Macron ready to 'open debate' on nuclear European defence
Apr 27, 2024
Latvians asked to turn basements into air-raid shelters
Apr 27, 2024
Russia hits Ukrainian energy sites in 'massive' attack
Apr 27, 2024
Russia shoots down 68 Ukrainian drones: defence ministry
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events